The two remaining studies investigated the prediction of EGFR mutation at exons 2–7 (EGFRvIII) and incorporated additional imaging features on their modelling such as location parameters, tumor growth model parameters and the peritumoral heterogeneity index. Here, EGFR is linked to neoplasm.